DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MEDI-507
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MEDI-507
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENCALERET
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ENCALERET
×
Maximum Phase:
2
First Approval:
None
UNII:
EF8081AQ6G
Molecule Type:
Small molecule
Molecular Formula:
C29H33ClFNO4
Molecular Weight:
514.04
AlogP:
6.2
PSA:
78.79
HBD:
3.0
HBA:
#RotB:
11.0
Source:
CX-072
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CX-072
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GTX-758
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Estrogen receptor alpha agonist
GTX-758
×
Maximum Phase:
2
First Approval:
None
UNII:
406GR1485Z
Molecule Type:
Small molecule
Molecular Formula:
C19H13F2NO3
Molecular Weight:
341.31
AlogP:
4.35
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LY3016859
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3016859
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPERINE
2
Small molecule
Investigational
Unknown
Unknown
Deglutition Disorders; Pain
Unknown
PIPERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
U71XL721QK
Molecule Type:
Small molecule
Molecular Formula:
C17H19NO3
Molecular Weight:
285.34
AlogP:
3.0
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MT-3724
2
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
80S Ribosome inhibitor
MT-3724
×
Maximum Phase:
2
First Approval:
None
UNII:
R23ZRN6GWR
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AR-12286
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AR-12286
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LANDOGROZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Muscular Diseases; Pancreatic Neoplasms
Growth/differentiation factor 8 inhibitor
LANDOGROZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
B1792M902R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD9150
2
Oligonucleotide
Investigational
Unknown
Unknown
Unknown
Unknown
AZD9150
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBOCTADEKIN
2
Protein
Investigational
Unknown
Unknown
Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Melanoma
Unknown
IBOCTADEKIN
×
Maximum Phase:
2
First Approval:
None
UNII:
X08H9UZ7TO
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUETMOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Crohn Disease; Liver Cirrhosis, Biliary
Fractalkine inhibitor
QUETMOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
G8NT4Q571B
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAPADENOSON
2
Small molecule
Investigational
Unknown
Unknown
Angina, Stable; Atrial Fibrillation
Adenosine A1 receptor partial agonist
CAPADENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
O519NVW73R
Molecule Type:
Small molecule
Molecular Formula:
C25H18ClN5O2S2
Molecular Weight:
520.04
AlogP:
5.51
PSA:
128.84
HBD:
2.0
HBA:
#RotB:
8.0
Source:
P276-00
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
P276-00
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IMR-687
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IMR-687
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAURODEOXYCHOLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Sepsis; Dermatitis, Atopic
Unknown
TAURODEOXYCHOLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
20668G0RPI
Molecule Type:
Small molecule
Molecular Formula:
C26H45NO6S
Molecular Weight:
499.71
AlogP:
3.4
PSA:
123.93
HBD:
4.0
HBA:
#RotB:
7.0
Source:
ARASERTACONAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Candidiasis, Vulvovaginal
Unknown
ARASERTACONAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
PR82C5R514
Molecule Type:
Small molecule
Molecular Formula:
C20H15Cl3N2OS
Molecular Weight:
437.78
AlogP:
7.02
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
PRADIGASTAT SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
PRADIGASTAT SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
X0EWE8TT2H
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N3NaO2
Molecular Weight:
477.46
AlogP:
6.65
PSA:
75.11
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NBTXR3
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NBTXR3
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SCYLLITOL
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Bipolar Disorder; Down Syndrome
Unknown
SCYLLITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
1VS4X81277
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.83
PSA:
121.38
HBD:
6.0
HBA:
#RotB:
0.0
Source:
AFN-1252
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Enoyl-[acyl-carrier-protein] reductase [NADH] inhibitor
AFN-1252
×
Maximum Phase:
2
First Approval:
None
UNII:
T3O718IKKM
Molecule Type:
Small molecule
Molecular Formula:
C22H21N3O3
Molecular Weight:
375.43
AlogP:
3.69
PSA:
75.44
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IPL-344
2
Unknown
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis
Unknown
IPL-344
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NCX 1000
2
Small molecule
Investigational
Unknown
Unknown
Hypertension, Portal
Unknown
NCX 1000
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C38H55NO10
Molecular Weight:
685.86
AlogP:
6.55
PSA:
154.66
HBD:
2.0
HBA:
#RotB:
14.0
Source:
PEGIPANERMIN
2
Protein
Investigational
Unknown
Unknown
Alzheimer Disease; Severe Acute Respiratory Syndrome
Unknown
PEGIPANERMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CINPANEMAB
2
Antibody
Investigational
Unknown
Unknown
Parkinson Disease
Alpha-synuclein inhibitor
CINPANEMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
W83JGQ40XX
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NOLPITANTIUM
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
NOLPITANTIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
NR72W2V70N
Molecule Type:
Small molecule
Molecular Formula:
C37H45Cl2N2O2+
Molecular Weight:
620.69
AlogP:
8.23
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
9.0
Source:
ABT-751
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Neuroblastoma
Tubulin beta inhibitor
ABT-751
×
Maximum Phase:
2
First Approval:
None
UNII:
WDT5V5OB9F
Molecule Type:
Small molecule
Molecular Formula:
C18H17N3O4S
Molecular Weight:
371.42
AlogP:
3.34
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
6.0
Source:
VELNEPERIT
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Neuropeptide Y receptor type 5 antagonist
VELNEPERIT
×
Maximum Phase:
2
First Approval:
None
UNII:
09BQ2KJ22J
Molecule Type:
Small molecule
Molecular Formula:
C17H24F3N3O3S
Molecular Weight:
407.46
AlogP:
3.32
PSA:
88.16
HBD:
2.0
HBA:
#RotB:
4.0
Source:
OBICETRAPIB
2
Small molecule
Investigational
Unknown
Unknown
Lipid Metabolism Disorders
Cholesteryl ester transfer protein inhibitor
OBICETRAPIB
×
Maximum Phase:
2
First Approval:
None
UNII:
8O74K609HN
Molecule Type:
Small molecule
Molecular Formula:
C32H31F9N4O5
Molecular Weight:
722.61
AlogP:
8.67
PSA:
105.09
HBD:
1.0
HBA:
#RotB:
11.0
Source:
DIMETHYLCURCUMIN
2
Small molecule
Investigational
Unknown
Unknown
Acne Vulgaris
Unknown
DIMETHYLCURCUMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
D60XLY608D
Molecule Type:
Small molecule
Molecular Formula:
C23H24O6
Molecular Weight:
396.44
AlogP:
4.46
PSA:
74.22
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PRM-151
2
Unknown
Investigational
Unknown
Unknown
Glaucoma; Polycythemia Vera; Primary Myelofibrosis; Idiopathic Pulmonary Fibrosis
Unknown
PRM-151
×
Maximum Phase:
2
First Approval:
None
UNII:
F68WAH6N5E
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FAD
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FAD
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEPADUTANT
2
Small molecule
Investigational
Unknown
Unknown
Abdominal Pain
Unknown
NEPADUTANT
×
Maximum Phase:
2
First Approval:
None
UNII:
XW59TYL1XH
Molecule Type:
Small molecule
Molecular Formula:
C45H58N10O13
Molecular Weight:
947.02
AlogP:
-4.11
PSA:
347.61
HBD:
13.0
HBA:
#RotB:
11.0
Source:
P-276-00
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Pancreatic Neoplasms; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Lymphoma, Mantle-Cell; Melanoma
Unknown
P-276-00
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H21NO5
Molecular Weight:
367.4
AlogP:
2.65
PSA:
94.14
HBD:
3.0
HBA:
#RotB:
3.0
Source:
OXALOBACTER FORMIGENES
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
OXALOBACTER FORMIGENES
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
151
152
153
154
155
156
157
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA